Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer ... https://t.co/FR8qxRpL7N
792 followers
1,945 followers
@OPDIVO_US $TRIL $BMY OPDIVO + YERVOY + TTI-621 https://t.co/vzZ2xmCSLA https://t.co/bocqxugkkw
7 followers
1,504 followers
$GILD was first to see potential of #CD47 with $FTSV. Who's going to be next with $TRIL? So much potential in so many terrible cancers. Would be great to see a combo breakthrough soon. https://t.co/GgOA3xLMsq https://t.co/XHVhbTr0DK